Objective
Acute traumatic coagulopathy (ATC) is associated with adverse outcomes including death. Previous studies examining ATC's relationship with mortality are limited by inconsistent criteria for syndrome diagnosis, inadequate control of confounding and single-center designs. In this study, we validated the admission international normalized ratio (INR) as an independent risk factor for death and other adverse outcomes after trauma and compared two common INR-based definitions for ATC.
Design
Multicenter prospective observational study.
Setting
Nine level I trauma centers in the United States.
Patients
1,031 blunt trauma patients with hemorrhagic shock.
Interventions
None.
Measurements and Main Results
INR exhibited a positive adjusted association with all-cause in-hospital mortality, hemorrhagic shock-associated in-hospital mortality, venous thromboembolism, and multiple organ failure. ATC affected 50% of subjects if defined as an INR >1.2 and 21% of subjects if defined by INR >1.5. After adjustment for potential confounders, ATC defined as an INR >1.5 was significantly associated with all-cause death (OR 1.88, p<0.001), hemorrhagic shock-associated death (OR 2.44, p=0.001), venous thromboembolism (1.73, p<0.001), and multiple organ failure (OR 1.38, p=0.02). ATC defined as an INR >1.2 was not associated with an increased risk for the studied outcomes.
Conclusions
Elevated INR on hospital admission is a risk factor for mortality and morbidity after severe trauma. Our results confirm this association in a prospectively-assembled multicenter cohort of severely injured patients. Defining ATC using an INR >1.5 but not an INR >1.2 identified a clinically-meaningful subset of trauma patients who, adjusting for confounding factors, suffered more adverse outcomes. Targeting future therapies for ATC to patients with an INR >1.5 may yield greater returns than using a lower INR threshold.